ClinicalTrials.Veeva

Menu

A Scalp Lotion Toimprove Sensitive Scalp Syndrome

C

Cosmetique Active

Status

Completed

Conditions

Alopecia
Sensitive Skin

Treatments

Other: Piroctone Olamine (PO), 2,4 Diaminopyrimidine oxide (2.4 DA) and Vichy mineralizing water

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.

Enrollment

100 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18 years
  • mild alopecia:
  • female: Ludwig type 1
  • male: Hamilton III to IV type

Exclusion criteria

  • Moderate or severe alopecia
  • Dandruff

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems